Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Heparin / Administration & Dosage”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Testing effectiveness (Phase 2)Looking for participantsNCT06394830
What this trial is testing

Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)

Who this might be right for
Interstitial CystitisBladder Pain Syndrome
Vaneltix Pharma, Inc. 50
Large-scale testing (Phase 3)Study completedNCT00362947
What this trial is testing

Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein Thrombosis

Who this might be right for
Thrombophlebitis
IRCCS Azienda Ospedaliero-Universitaria di Bologna 664
Post-approval studies (Phase 4)Study completedNCT02675647
What this trial is testing

Heparin Based on Ideal Body Weight for Cardiopulmonary Bypass in Obese Patients

Who this might be right for
Cardiac SurgeryCardiopulmonary BypassObese Patients (BMI ≥ 30 kg/m²)
University Hospital, Strasbourg, France 60
Post-approval studies (Phase 4)UnknownNCT01531829
What this trial is testing

Low Dose Rt-PA for Acute Normotensive Pulmonary Embolism With RVD

Who this might be right for
Pulmonary ThromboembolismsPulmonary Embolism
Beijing Chao Yang Hospital 460
Large-scale testing (Phase 3)UnknownNCT02486666
What this trial is testing

Pilot Feasibility and Safety of Administering Weight Adjusted Fixed LMWH Dose

Who this might be right for
Venous Thromboembolism
Hamilton Health Sciences Corporation 20
Post-approval studies (Phase 4)UnknownNCT01917799
What this trial is testing

Aspirin, Heparin and Miscarriage

Who this might be right for
PregnancyMiscarriage
University of Khartoum 150
Testing effectiveness (Phase 2)Study completedNCT01419977
What this trial is testing

Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose Low-molecular-weight Heparin (LMWH) Versus Placebo

Who this might be right for
Sickle Cell DiseaseVaso-occlusive Crisis
Duke University 34
Not applicableUnknownNCT04671160
What this trial is testing

Impact of Continuous Veno-venous Hemodiafiltration on Efficacy of Administration of Prophylactic Doses of Enoxaparin or Fondaparinux in Critically Ill Patients.

Who this might be right for
Assessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving Anticoagulant Prophylaxis
Medical University of Gdansk 80
Early research (Phase 1)Study completedNCT05265676
What this trial is testing

Bioequivalence Study of a Generic Enoxaparin Sodium to Clexane® After Single Subcutaneous Dose in Healthy Human Subjects

Who this might be right for
Healthy
Venus Remedies Limited 24
Testing effectiveness (Phase 2)Ended earlyNCT01532544
What this trial is testing

Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe Sepsis

Who this might be right for
Pneumonia
Thrombologic ApS 5
Large-scale testing (Phase 3)UnknownNCT04861922
What this trial is testing

Unfractioned Heparin for Treatment of Sepsis Caused by Abdominal Infection

Who this might be right for
SepsisGram-Negative Bacterial InfectionsHeparin
The Third Xiangya Hospital of Central South University 100
Not applicableStudy completedNCT00781690
What this trial is testing

Reduction of Heparin Dose in Dialysis With Evodial System

Who this might be right for
Chronic Kidney Failure
Vantive Health LLC 53
Early research (Phase 1)UnknownNCT05788900
What this trial is testing

Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Intravenous Administration

Who this might be right for
Anticoagulant
Blau Farmaceutica S.A. 68
Testing effectiveness (Phase 2)Study completedNCT02206087
What this trial is testing

Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of PER977 Following Heparin

Who this might be right for
Healthy
Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. 60
Not applicableUnknownNCT04462614
What this trial is testing

Possibility to Stop Perdialytic Heparin Therapy in Hemodialysed Patients With HeprAN ™ Membrane and Treated by Long-term Anticoagulation With VKA

Who this might be right for
Chronic HemolysisVKAAnticoagulants / Administration & Dosage+7 more
CHU de Reims 49
Large-scale testing (Phase 3)Study completedNCT00182403
What this trial is testing

Fixed Dose Heparin Study

Who this might be right for
Venous ThromboembolismDeep Vein ThrombosisPulmonary Embolism
McMaster University 866
Large-scale testing (Phase 3)Study completedNCT02135770
What this trial is testing

Impact of Low Dose Unfractionated Heparin Treatment on Inflammation in Sepsis

Who this might be right for
Severe Sepsis With Septic ShockSevere Sepsis Without Septic Shock
Indonesia University 115
Early research (Phase 1)UnknownNCT05788913
What this trial is testing

Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Subcutaneous Administration

Who this might be right for
Anticoagulant
Blau Farmaceutica S.A. 68